Biomed Realty Trust (NYSE: BMR) reported Q4 FFO of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $165.66 million versus the consensus estimate of $166.9 million.

Biomed Realty Trust sees FY2015 FFO of $1.39-$1.49, versus the consensus of $1.44.

For earnings history and earnings-related data on Biomed Realty Trust (BMR) click here.